MCID: MXD009
MIFTS: 11

Mixed Cell Type Kidney Wilms' Tumor

Categories: Cancer diseases, Nephrological diseases

Aliases & Classifications for Mixed Cell Type Kidney Wilms' Tumor

MalaCards integrated aliases for Mixed Cell Type Kidney Wilms' Tumor:

Name: Mixed Cell Type Kidney Wilms' Tumor 12
Mixed Cell Type Kidney Wilms' Tumour 12
Mixed Cell Type Renal Wilms Tumour 12
Mixed Cell Type Renal Wilms Tumor 12
Mixed Cell Type Wilms' Tumor 71

Classifications:



External Ids:

Disease Ontology 12 DOID:5179
NCIt 49 C9149
UMLS 71 C0279611

Summaries for Mixed Cell Type Kidney Wilms' Tumor

MalaCards based summary : Mixed Cell Type Kidney Wilms' Tumor, is also known as mixed cell type kidney wilms' tumour, and has symptoms including abdominal pain The drugs Vincristine and Dactinomycin have been mentioned in the context of this disorder. Affiliated tissues include kidney.

Related Diseases for Mixed Cell Type Kidney Wilms' Tumor

Symptoms & Phenotypes for Mixed Cell Type Kidney Wilms' Tumor

UMLS symptoms related to Mixed Cell Type Kidney Wilms' Tumor:


abdominal pain

Drugs & Therapeutics for Mixed Cell Type Kidney Wilms' Tumor

Drugs for Mixed Cell Type Kidney Wilms' Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
2
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
3
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
4
Etoposide Approved Phase 3 33419-42-0 36462
5
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
6
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
7 Antibiotics, Antitubercular Phase 3
8 Immunologic Factors Phase 3
9 Etoposide phosphate Phase 3
10 Alkylating Agents Phase 3
11 Anti-Infective Agents Phase 3
12 Immunosuppressive Agents Phase 3
13 Anti-Bacterial Agents Phase 3
14
Liposomal doxorubicin Phase 3 31703
15 Tubulin Modulators Phase 3
16 Antirheumatic Agents Phase 3
17 Antimitotic Agents Phase 3

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Nephroblastoma (Wilms Tumour) Clinical Trial And Study Unknown status NCT00047138 Phase 3 carboplatin;cyclophosphamide;doxorubicin hydrochloride;etoposide;vincristine sulfate

Search NIH Clinical Center for Mixed Cell Type Kidney Wilms' Tumor

Genetic Tests for Mixed Cell Type Kidney Wilms' Tumor

Anatomical Context for Mixed Cell Type Kidney Wilms' Tumor

MalaCards organs/tissues related to Mixed Cell Type Kidney Wilms' Tumor:

40
Kidney

Publications for Mixed Cell Type Kidney Wilms' Tumor

Variations for Mixed Cell Type Kidney Wilms' Tumor

Expression for Mixed Cell Type Kidney Wilms' Tumor

Search GEO for disease gene expression data for Mixed Cell Type Kidney Wilms' Tumor.

Pathways for Mixed Cell Type Kidney Wilms' Tumor

GO Terms for Mixed Cell Type Kidney Wilms' Tumor

Sources for Mixed Cell Type Kidney Wilms' Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....